Year-to-Date Revenue Reaches $5.8 Million, Up 178%; Beamer Acquisition and Multi-Sector Customer Wins Expand Market Reach
With filing of 10-Q, Company believes it has met the requirements to regain compliance with Nasdaq
Read More
New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose a surgery date.
Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards, and anesthesia planning before elective cosmetic surgery.
Read More
ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure volumes reinforce growing demand for comprehensive facial rejuvenation planning.
News Release Highlights:
Forte Group's wholly-owned subsidiary, Naturo Group Enterprises Inc., has received a Liquor Co-Packing Licence, authorizing the Company to pursue beverage alcohol co-packing operations within a designated 10,000-square-foot licensed area of its 40,000-square-foot manufacturing facility in Bridesville, British Columbia, expanding the Company's permitted manufacturing capabilities.
The licence positions Forte Group to evaluate and pursue future contract manufacturing opportunities with licensed beverage alcohol brands, as well as non-alcoholic "mock" or zero-proof liquor-style beverages, leveraging its broader production platform to support potential new revenue verticals and increased facility utilization.
In parallel, the Company is evaluating the pursuit of an additional liquor licence that would permit direct sales to provincial liquor distribution authorities, in response to advanced discussions with an arm's-length strategic third party regarding a potential alcohol co-manufacturing relationship.
MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of Huntington's Disease. These designations are awarded to drugs intended for the safe and effective treatment of rare diseases and provide MMJ with critical incentives, including: Seven Years of Market Exclusivity: Protecting MMJ's innovations upon FDA approval. Tax Credits: Applied to qualified clinical testing expenses. Waived FDA Fees: Significantly reducing the capital barriers to drug commercialization. Accelerated Review: Streamlining the path to provide relief to patients with unmet medical needs.
Read More
LIVE FOREVER HEALTH™ UNVEILS FULL-STACK HORMONE & TELEMEDICINE FRANCHISE MODEL, PIONEERING LONGEVITY CARE IN ALL 50 STATES
The Specialized Health Leader Offers a Turnkey System for Entrepreneurs to Capitalize on the Booming $27 Billion Hormone Replacement Market with Proven Clinical Protocols and Transparent Pricing.
Introducing the News: The Core Announcement
Read More
From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing facial harmony as the foundation of modern aesthetics.
Read More
Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the United States with Prescribed Medical Cannabis
Read MoreMilestone Advances Blue Gold's Commitment to a World-Class Digital Gold Ecosystem Rooted in Trust, Transparency, and Institutional Standards
Read MoreTax professionals say changing payroll services may stop future mistakes, but it does not erase unpaid taxes or filing errors already on record with the IRS.
Read More
